or Try an Advanced Search...

    DNA Sequencing Stocks List

    Symbol Grade Name % Change
    HELX D Franklin Genomic Advancements ETF -1.73
    QGEN D Qiagen N.V. 0.61
    ILMN F Illumina, Inc. -1.35
    QSI F Quantum-Si -1.31
    PACB F Pacific Biosciences of California, Inc. 4.29
    HYPR F Hyperfine, Inc. -10.99
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Devices
    Related Stock Lists: Biology Biotechnology Molecular Biology Life Sciences Acid Genome Genomics Bioinformatics Jonathan Rothberg Lab Testing Polymerase Chain Reaction Scanner Clinical Research Cloning Companion Diagnostic Consumable Products DNA Drug Discovery ETF Emerging Technologies

    Related ETFs - A few ETFs which own one or more of the above listed DNA Sequencing stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 8.89
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 7.67
    BBH D Market Vectors Biotech ETF 6.31
    EDOC F Global X Telemedicine & Digital Health ETF 6.07
    BIS A ProShares UltraShort Nasdaq Biotechnology 5.67
    View all DNA Sequencing ETFs...
    Compare ETFs
    Compare EKG to BIS Compare EKG to EDOC Compare GNOM to EKG

        DNA Sequencing Stocks Recent News

        Date Stock Title
        Apr 18 QSI Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
        Apr 18 PACB PacBio cut to Neutral at Goldman Sachs after guidance cut
        Apr 18 PACB Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
        Apr 17 PACB PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
        Apr 17 ILMN Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
        Apr 17 HYPR Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
        Apr 16 PACB PacBio falls after issuing guidance below expectations
        Apr 16 PACB PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
        Apr 15 ILMN European Commission approves Illumina’s proposed Grail split
        Apr 12 ILMN Illumina’s Grail divestment approved by EU (update)
        Apr 12 ILMN Illumina's planned divestment of GRAIL approved by the European Commission
        Apr 12 ILMN UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail
        Apr 12 ILMN EU approves Illumina's plan to divest cancer test maker Grail
        Related Industries: Biotechnology Diagnostics & Research Medical Devices
        Related Stock Lists: Biology Biotechnology Molecular Biology Life Sciences Acid Genome Genomics Bioinformatics Jonathan Rothberg Lab Testing Polymerase Chain Reaction Scanner Clinical Research Cloning Companion Diagnostic Consumable Products DNA Drug Discovery ETF Emerging Technologies
        DNA Sequencing

        Browse All Tags